| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | Long-Term Outcomes of Patients with Epstein-barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in an Expanded Access Program Study | Prockop, S.; Reshaf, R.; Tsai, D.; Bunin, N.; Abu-Arja, R.; Mahadeo, K.; Weng, W.; Van Besien, K.; Loeb, D.; Nasta, S. D.; Nemecek, E.; Hiremath, M.; Yue, S.; Sun, Y.; Navarro, W.; Nikiforow, S. | American Journal of Transplantation |
